Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 8;14(14):2821.
doi: 10.3390/nu14142821.

B Vitamins and Incidence of Advanced Age-Related Macular Degeneration: The Alienor Study

Affiliations

B Vitamins and Incidence of Advanced Age-Related Macular Degeneration: The Alienor Study

Bénédicte M J Merle et al. Nutrients. .

Abstract

B vitamins may protect against age-related macular degeneration (AMD). We evaluated the associations of dietary intake and serum vitamins with the incidence of advanced AMD in the Alienor study. The Alienor study is a prospective population-based cohort of 963 residents of Bordeaux, France, who were 73 years or older at baseline (2006-2008). Examinations were performed every two years over an eight-year period. The incidence of AMD is based on retinal fundus photographs and spectral-domain optical coherence tomography examinations. Among the 861 included participants, 93 developed incident AMD during a median follow-up time of 9.8 years. Participants with normal serum folate (≥10 nmol/L) significantly had a 51% reduced risk for AMD in the fully adjusted Cox model (HR, 0.49 [95% CI, 0.25-0.95], p = 0.036). Participants with a higher dietary intake of B5 and B6 vitamins had a lower risk for developing AMD of up to 28% (HR, 0.72 for 1-SD increase [0.53-0.99], p = 0.049; HR, 0.90 [0.81-0.99], p = 0.049, respectively). This cohort study of older adults suggests a strong association between a normal serum folate status, a high dietary intake of B5 and B6 and a lower risk for developing advanced AMD. Adopting a healthy diet rich in B vitamins may help to reduce vision loss due to AMD.

Keywords: age-related macular degeneration; cohort; epidemiology; folate; nutrition; population; risk; vitamins B.

PubMed Disclaimer

Conflict of interest statement

Bénédicte Merle: Travel fees from Thea Pharma. Stéphanie Barthès: none. Audrey Cougnard-Gregoire: Travel fees from Laboratoires Théa. Catherine Féart: consultant for Laboratoire Lescuyer and Synadiet, travel fees from Nutricia Research. Marie-Noëlle Delyfer: consultant for Allergan, Horus Pharma, Bayer, Laboratoires Théa, Novartis. Cécile Delcourt: consultant for Allergan, Bausch + Lomb, Laboratoires Théa, Novartis. Jean-François Korobelnik: consultant for Allergan, Bayer, Baush&Lomb, Beaver Visitec, Horus, Krys, Kanghong, NanoRetina, Novartis, Novonordisk, Oxurion, Roche, Thea. The funders had no role; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Association between serum folate and incidence of advanced AMD adjusted for age, sex, smoking status, HDL-cholesterol, genetic risk score, oral supplementation for AMD, body mass index and physical activity. Data from the Alienor Study 2001–2017 (n = 654). Serum folate was modeled using p-spline with 4 degrees of freedom in the Cox model. HR: hazard ratio.

References

    1. Fleckenstein M., Keenan T.D.L., Guymer R.H., Chakravarthy U., Schmitz-Valckenberg S., Klaver C.C., Wong W.T., Chew E.Y. Age-related macular degeneration. Nat. Rev. Dis. Prim. 2021;7:31. doi: 10.1038/s41572-021-00265-2. - DOI - PubMed
    1. Sobrin L., Seddon J.M. Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog. Retin. Eye Res. 2014;40:1–15. doi: 10.1016/j.preteyeres.2013.12.004. - DOI - PMC - PubMed
    1. Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C., Farber M.D., Gragoudas E.S., Haller J., Miller D.T., et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272:1413–1420. doi: 10.1001/jama.1994.03520180037032. - DOI - PubMed
    1. Delcourt C., Carriere I., Delage M., Barberger-Gateau P., Schalch W., Group P.S. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: The POLA Study. Invest. Ophthalmol. Vis. Sci. 2006;47:2329–2335. doi: 10.1167/iovs.05-1235. - DOI - PubMed
    1. Ma L., Dou H.L., Wu Y.Q., Huang Y.M., Huang Y.B., Xu X.R., Zou Z.Y., Lin X.M. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: A systematic review and meta-analysis. Br. J. Nutr. 2012;107:350–359. doi: 10.1017/S0007114511004260. - DOI - PubMed